Gut-Brain Axis and Rehabilitation: Study on the Effects of C-Mill Technology on the Intestinal Microbiota of Parkinson's Disease Patients
The GM-REHAB-2025 study aims to evaluate the impact of physiotherapy interventions using the C-Mill treadmill, with and without semi-immersive virtual reality, on gut microbiota and metabolic parameters in patients with Parkinson's disease. Three groups will be involved: one undergoing conventional physiotherapy, one treated with the C-Mill without virtual reality (VR), and one treated with C-Mill technology combined with VR. Clinical assessments and the collection of biological samples (stool, serum, and plasma) will be carried out at three time points: at baseline, at the end of treatment (21 days), and after 3 months.
• Diagnosis of PD according to the Movement Disorder Society Clinical
• Diagnostic Criteria for Parkinson's Disease
• Age comprised between 40 to 70 years
• Patients with moderate to advanced disease (2 ≤ Hoehn and Yahr classification grade ≤ 4)
• Individuals able to walk independently (FAC \> 2)